Boston Scientific Corp. is the latest pelvic mesh manufacturer to seek discovery about a company that purchases medical accounts receivable—and that it accuses of driving up medical expenses claimed by plaintiffs.
Medstar Funding L.C. and Medstar president Daniel Christensen have moved to quash or modify subpoenas issued by mesh defendants Boston Scientific, C.R. Bard Inc. and American Medical Systems Inc. Medstar argues that the subpoenas directed to medical service providers would inappropriately reveal the amounts that MedStar pays to medical service providers for accounts receivable.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
